Application of optogenetics in iPS cell transplantation therapy for ischemic stro

光遗传学在iPS细胞移植治疗缺血性卒中中的应用

• 批准号: 8830148
• 负责人: ROBERT E GROSS
• 金额: $ 34.13万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-01 至 2019-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8830148
• 关键词: Address; Adult; Animal Model; Animals; Attention; Autologous Transplantation; Basic Science; Biological Neural Networks; Biophysics; Brain; Cations; Cell Differentiation process; Cell Survival; Cell Transplantation; Cell Transplants; Cells; Cessation of life; Clinical; Clinical Research; Combined Modality Therapy; Coupled; Cultured Cells; Data; Development; Dose; Electrophysiology (science); Embryo; Environment; Ethical Issues; Goals; Growth Factor; Health; Human; Hypoxia; Imaging Techniques; In Vitro; Investigation; Ischemia; Ischemic Stroke; Laboratory Research; Lasers; Life; Light; Luciferases; Maps; Measurement; Measures; Membrane; Methods; Modeling; Molecular; Molecular and Cellular Biology; Mus; Natural regeneration; Nature; Neurodegenerative Disorders; Neuronal Differentiation; Neuronal Injury; Neurons; Neurosciences; Pathway interactions; Patients; Peripheral; Pluripotent Stem Cells; Property; Proteins; Recovery of Function; Replacement Therapy; Research; Rodent; Slice; Somatic Cell; Specificity; Stem cell transplant; Stem cells; Stimulus; Stroke; Structure; Survival Rate; Techniques; Technology; Testing; Thalamic structure; Transplantation; Vibrissae; angiogenesis; barrel cortex; base; brain cell; brain tissue; cell type; chemical genetics; clinical application; clinically relevant; coelenterazine; disability; effective therapy; embryonic stem cell; functional restoration; implantation; improved; in vivo; induced pluripotent stem cell; injured; innovation; membrane activity; mouse model; nerve stem cell; neural circuit; neural precursor cell; neurogenesis; novel; novel strategies; optical imaging; optogenetics; post stroke; pre-clinical; preconditioning; protective effect; public health relevance; reconstruction; regenerative; regenerative therapy; rehabilitation strategy; repaired; response; restoration; somatosensory; stem; stem cell therapy; stroke therapy; tissue repair; tool

DESCRIPTION (provided by applicant): Stroke remains a leading cause of human death and disability while very few effective treatments are available for stroke patients. Stem cell transplantation therapy provides the possibility to regenerate and repair damaged brain tissues after ischemic stroke. The investigation takes a comprehensive and unprecedented approach to promote both trophic supports as well as cell replacement potential of pluripotent stem cells to develop a highly effective stem cell therapy for ischemic stroke. We propose that enhancing the survival and regenerative properties of transplanted cells as well as an improved host environment are critical for a successful stem cell stroke therapy. To reach this goal, our previous and preliminary studies have demonstrated a marked protective effect and increased functional benefits of combining hypoxia preconditioning (HP) and other regenerative strategies including optogenetic techniques and up regulated multiple trophic factors in the ischemic brain promoted by peripheral stimulation. Our central hypothesis is that a combination strategy of HP-primed NPCs subjected to optogenetic manipulations and improved host environment will allow better survival of transplanted as well as endogenous cells, enhance neurogenesis/angiogenesis via both exogenous and endogenous mechanisms, and results in optimal tissue repair and functional recovery after stroke. In neural progenitor cells (NPCs) derived from mouse induced pluripotent stem (iPS) cells, we will express the blue light- sensitive channelrhodopsin (ChR) channels and test the possibility that activation of ChRs by blue light stimuli or by the luciferase/ChR proten (luminopsis) substrate coelenterazine (CTZ) is a feasible and effective method to improve and evaluate neuronal differentiation, integration into host neural networks and neuronal connections after transplantation into the ischemic brain. We will examine the strategies to promote tissue repair and provide evidence for the morphological and functional restoration of ischemic brain structures in the unique barrel cortex ischemic stroke model of mice. We will demonstrate the feasibility and benefits of expression/activation of ChR channels in iPS-NPCs in vitro (Specific Aim 1) and after implantation into the post-ischemic barrel cortex (Aim 2). Based on the well-defined whisker- thalamus-barrel cortex pathway, structural and functional restoration of disrupted whisker-barrel activities will be evaluated usin a combination of cell specific and neuronal pathway specific measurements, including optogenetic, electrophysiological and optical imaging recordings (Aim 3). The proposal is from three research laboratories with complementary expertise in biophysics, electrophysiology, cellular/molecular biology and clinical neurosciences. The demonstration of cellular and tissue repairing benefits of iPS-NPCs in a particular brain structure is critical for the development of mechanism based cell transplantation therapy and the strategies will have great impacts on pre-clinical and clinical studies.

描述（由申请人提供）：中风仍然是人类死亡和残疾的主要原因，而中风患者的有效治疗方法很少。干细胞移植治疗为缺血性脑卒中后受损脑组织的再生和修复提供了可能。这项研究采取了一种全面和前所未有的方法来促进多能干细胞的营养支持和细胞替代潜力，以开发一种高效的缺血性中风干细胞治疗方法。我们认为，提高移植细胞的存活和再生特性以及改善宿主环境对于成功的干细胞中风治疗至关重要。为了实现这一目标，我们先前和初步的研究已经证明了缺氧预处理（HP）和其他再生策略（包括光遗传学技术和外周刺激促进的缺血性脑中上调的多种营养因子）相结合的显著保护作用和增加的功能益处。我们的中心假设是，HP致敏的NPC进行光遗传学操作和改善的宿主环境的组合策略将允许移植细胞以及内源性细胞更好的存活，通过外源性和内源性机制增强神经发生/血管生成，并导致中风后最佳的组织修复和功能恢复。在小鼠诱导多能干细胞（iPS）衍生的神经前体细胞（NPC）中，我们将表达蓝光敏感通道视紫红质（ChR）通道，并测试蓝光刺激或荧光素酶/ChR蛋白激活ChR的可能性。（Luminopsis）底物腔肠素（CTZ）是促进和评价神经元分化的一种可行而有效的方法，在移植到缺血性脑中后整合到宿主神经网络和神经元连接中。我们将研究促进组织修复的策略，并在小鼠独特的桶皮质缺血性中风模型中为缺血脑结构的形态和功能恢复提供证据。我们将证明在体外iPS-NPC中表达/激活ChR通道的可行性和益处（具体目标1）以及植入缺血后的桶状皮质（目标2）。基于明确定义的须-丘脑-桶皮质通路，将使用细胞特异性和神经元通路特异性测量的组合来评估中断的须-桶活性的结构和功能恢复，包括光遗传学、电生理学和光学成像记录（目的3）。该提案来自三个研究实验室，它们在生物物理学、电生理学、细胞/分子生物学和临床神经科学方面具有互补的专业知识。iPS-NPCs在特定脑结构中的细胞和组织修复益处的证明对于基于机制的细胞移植治疗的发展至关重要，并且该策略将对临床前和临床研究产生重大影响。